Telehealth Narcolepsy Prescribing: What Psychiatric NPs Can Do in New York

If you’re a psychiatrist or psychiatric nurse practitioner considering treating narcolepsy patients via telehealth, you’re probably wondering: Can I actually prescribe stimulants remotely? What are the legal hoops? Is this even worth it given the regulatory complexity?

Short answer: Yes, you can manage narcolepsy via telehealth — but the details depend heavily on your credentials and the state where your patients live. Let’s cut through the noise and talk about what psychiatrists and PMHNPs can realistically do in 2025-2026, state by state.

Why Narcolepsy Matters for Psychiatrists & PMHNPs

Narcolepsy affects roughly 1 in 2,000 Americans — about 160,000 people nationwide. It’s a rare neurological sleep disorder, but here’s the thing: most of these patients can’t find specialists to treat them. Sleep medicine clinics have months-long waitlists, and many primary care providers aren’t comfortable managing the controlled substances these patients need.

That’s where you come in. Psychiatrists and PMHNPs already prescribe stimulants for ADHD. The same medications (amphetamines, methylphenidate, modafinil) are first-line treatments for narcolepsy’s excessive daytime sleepiness. You have the expertise. The question is whether you have the legal authority — and whether the business model makes sense.

The opportunity: Narcolepsy patients need ongoing medication management. They’re not one-and-done consults. Most require monthly follow-ups (especially on Schedule II stimulants), meaning predictable recurring appointments. These patients are often desperate for care and willing to pay out-of-pocket or maintain good insurance compliance. For providers looking to build a stable telehealth panel, narcolepsy patients can be an ideal fit.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

What Psychiatrists (MD/DO) Can Do Via Telehealth

If you’re a board-certified psychiatrist, you have full prescriptive authority for narcolepsy in every state. No categorical medication restrictions exist — Schedule II stimulants, Schedule IV wakefulness promoters (modafinil/armodafinil), even sodium oxybate (the tightly controlled GHB medication for cataplexy). You can prescribe them all, provided you:

1. Are licensed in the patient’s state (or hold an appropriate interstate compact license where available)
2. Follow federal DEA rules for controlled substances
3. Comply with any state-specific telehealth prescribing laws

Federal Rules: The DEA Telehealth Waiver (Extended Through 2025)

Here’s the critical piece: During the COVID-19 pandemic, the DEA suspended the Ryan Haight Act requirement that controlled substance prescriptions (Schedule II-V) require an initial in-person medical evaluation. That waiver has been extended through December 31, 2025, meaning you can currently initiate Schedule II stimulants for narcolepsy patients via video visit without ever meeting them in person.

After 2025, the rules are uncertain. The DEA may implement a special telemedicine registration that allows continued prescribing, or they may reinstate the in-person requirement. Smart providers are preparing for both scenarios — either by establishing local partnerships for initial in-person exams if needed, or by advocating for permanent telehealth flexibility (which many professional organizations support given the positive patient outcomes during the pandemic).

State-Level Variations That Matter

While psychiatrists have uniform prescriptive authority, state telehealth laws create some wrinkles:

Florida is the biggest outlier. Florida law prohibits prescribing Schedule II controlled substances via telehealth unless it’s for:

• Psychiatric treatment (ADHD, etc.)
• Inpatient hospital care
• Hospice/palliative care
• Chronic pain management

The problem: Narcolepsy isn’t a psychiatric condition by diagnostic classification (it’s G47.4x in ICD-10, a neurological disorder). Technically, a Florida-licensed psychiatrist treating pure narcolepsy via telehealth shouldn’t prescribe Adderall or other Schedule IIs under state law — even though federal law currently allows it.

Practical workaround: Many providers prescribe modafinil or armodafinil (Schedule IV) for Florida patients, which is allowed via telehealth as of 2022. Or, if the patient has comorbid ADHD or psychiatric symptoms, the stimulant can be justified under ‘psychiatric treatment.’ Some providers also arrange one initial in-person visit with a local physician to satisfy any stricter interpretation.

Other states (California, New York, Illinois, Pennsylvania, Texas) don’t have Florida’s specific prohibition. As long as you’re meeting standard-of-care telehealth requirements — video visit (not audio-only for controlled substances), proper documentation, PDMP checks — you can manage narcolepsy remotely without extra in-person requirements.

Clinical Workflow for Psychiatrists

A typical narcolepsy telehealth workflow looks like this:

1. Initial Evaluation (30-45 min): Review the patient’s sleep study results (polysomnogram + MSLT showing short sleep latency and SOREMPs, confirming narcolepsy diagnosis). Most patients come with a diagnosis already — you’re not doing the sleep study yourself. Document excessive daytime sleepiness symptoms, rule out other causes (sleep apnea, medications, psychiatric conditions), and establish the treatment plan.

2. Prescribing: Check your state’s PDMP (prescription drug monitoring program) — this is mandatory in almost all states before prescribing controlled substances. E-prescribe the medication using a DEA-compliant electronic prescribing system. For Schedule II drugs, you cannot provide refills by law, so you’ll need to issue a new prescription each month (some states allow post-dated prescriptions to cover 90 days, but the patient can only fill one 30-day supply at a time).

3. Follow-Up Visits (15-20 min monthly initially, then every 3 months for stable patients): Assess symptom improvement using standardized tools (Epworth Sleepiness Scale), screen for side effects (blood pressure, heart rate, weight, insomnia), adjust doses as needed. These visits code as 99213 or 99214 E/M visits for billing purposes.

4. Care Coordination: Maintain communication with the patient’s sleep specialist or primary care doctor (with patient consent). You’re managing the medications; they’re handling the underlying sleep architecture and any other complications.

Documentation requirements: Treat these like any psychiatric med check. Standard of care in telehealth means thorough notes: presenting symptoms, mental status exam, medication review, labs/vitals discussed, informed consent documented. If you do this, your malpractice coverage will support it, and regulators won’t have grounds to challenge your practice.

Reimbursement Reality for Psychiatrists

Insurance: Most commercial payers and Medicare now reimburse telehealth mental health visits at parity with in-person (thanks to COVID-era policy changes extended in many states). You can bill standard E/M codes (99213/99214) for narcolepsy med checks. Medicare allows ~$110-130 for a 99214; private insurance varies but often $140-200 depending on your contract.

One caveat: Some insurers process narcolepsy (a neurological code) under medical benefits rather than behavioral health. This can sometimes avoid mental health network restrictions, but double-check your credentialing.

Cash-pay: Given the administrative burden of prior authorizations for narcolepsy meds and lower reimbursement rates for mental health providers (private insurers pay mental health clinicians about 22% less than other specialists for similar services in some states), many psychiatrists opt for cash-pay or concierge models. A 15-minute narcolepsy follow-up might run $100-150 out-of-pocket, which patients often find worth it given the shortage of specialists.

Volume potential: Because narcolepsy patients need monthly visits during dose adjustments, you can build a steady panel. If you see 20 narcolepsy patients monthly at $100-120 per visit (insurance or cash), that’s $2,000-2,400/month in predictable revenue from that patient subset alone — without the lengthy psychotherapy sessions that eat up more time per patient.

What PMHNPs Can Do: State-by-State Reality Check

Here’s where it gets complicated. Nurse practitioners’ authority to prescribe narcolepsy medications varies wildly by state. In some states, an experienced PMHNP functions nearly identically to a psychiatrist. In others, you can’t prescribe stimulants at all without jumping through hoops.

Full-Practice States (PMHNPs Can Manage Narcolepsy Independently After Experience)

New York: After accumulating 3,600 hours of supervised practice (about 2 years full-time), a PMHNP can practice and prescribe completely independently — no collaborative agreement required. You can prescribe Schedule II-V controlled substances on your own, including Adderall, Ritalin, modafinil, sodium oxybate. Before hitting that threshold, you need a written collaborative agreement with a physician that covers controlled substances in your scope.

Illinois: NPs can obtain Full Practice Authority (FPA) after completing 4,000 hours of collaborative practice plus 250 hours of additional pharmacology education. With FPA, you can prescribe legend drugs and Schedule II-V controlled substances independently. Illinois does require FPA-NPs to maintain a ‘consultation relationship’ with a physician for Schedule II opioids (monthly consult documented) and for benzodiazepines prescribed beyond 120 days — but stimulants aren’t included in those restrictions. You can manage narcolepsy independently.

California: California is transitioning to NP independence via AB 890. As of 2023, NPs can become ‘103 NPs’ (practicing in physician-supervised group settings without individual oversight) and prescribe Schedule II-V drugs. After 3+ years and 4,600+ hours as a 103 NP, you can apply for ‘104 NP’ status starting in 2026, which grants full independence. Until then, you need physician-approved ‘standardized procedures’ that authorize specific controlled substances. For narcolepsy, your collaborating physician would need to approve stimulant prescribing in your protocol.

Practical takeaway for these states: If you’re an experienced PMHNP in NY, IL, or (soon) CA, you can build a telehealth narcolepsy practice that looks almost identical to a psychiatrist’s — independently diagnosing, prescribing, and managing patients.

Restricted-Practice States (Physician Oversight Required, Often with Limits)

Texas: Texas is one of the most restrictive states for NP prescribing. You must have a Prescriptive Authority Agreement with a supervising physician. The real kicker: Texas law prohibits NPs from prescribing Schedule II drugs for outpatients except in narrow circumstances (hospital inpatient care or hospice).

That means if you’re a Texas PMHNP, you cannot prescribe Adderall, Ritalin, or other Schedule II stimulants for narcolepsy patients in a typical telehealth setting. Your supervising physician would have to write those prescriptions. You can prescribe Schedule III-V drugs (like modafinil, which is Schedule IV), but for the primary narcolepsy treatments, you’re limited.

Why this matters: Texas ranks last nationally in mental health access. The demand is enormous. But NPs can’t fully meet it for narcolepsy care. Platforms serving Texas patients need physicians on staff, or NP-MD teams where the physician handles Schedule II scripts.

Florida: Florida requires physician collaborative agreements for PMHNPs (psychiatric NPs were explicitly excluded from the state’s autonomous NP law). Florida NPs can prescribe Schedule II drugs, but only for 7-day supplies maximum — unless you’re a state-certified ‘psychiatric nurse’ prescribing psychiatric medications, which gets an exemption.

Here’s the ambiguity: Is a stimulant for narcolepsy a ‘psychiatric medication’? Probably not by strict interpretation (narcolepsy is neurological, not psychiatric). So a Florida PMHNP treating narcolepsy would be stuck writing weekly prescriptions, which is impractical. Most Florida NPs either:

• Work with their collaborating physician to prescribe longer supplies
• Use modafinil/armodafinil (Schedule IV, no 7-day limit)
• Refer Schedule II cases to their supervising psychiatrist

Florida’s telehealth law also complicates this: the state prohibits prescribing Schedule II via telehealth for non-psychiatric conditions. So even your collaborating physician might need to see the patient in-person initially or arrange an exception.

Pennsylvania: Pennsylvania requires written collaborative agreements for all CRNPs (certified registered nurse practitioners). You can prescribe Schedule II drugs, but only for 30-day supplies — then you need physician involvement for renewal or extension. Schedule III-IV can be prescribed for 90 days.

This isn’t a dealbreaker for narcolepsy (monthly visits are standard anyway for stimulant refills), but it does mean extra administrative coordination with your collaborating physician. Your agreement must explicitly list the controlled substances you’re authorized to prescribe.

Quick State Comparison Table

What This Means for PMHNP Practice

If you’re a PMHNP considering narcolepsy care:

In full-practice states (NY, IL, CA post-2026), you can build a thriving independent telehealth practice once you’ve met experience requirements. You’ll have the same clinical and prescriptive authority as a psychiatrist for these patients.

In restricted states (TX, FL, PA), you need to work within a collaborative model. That might mean:

• Partnering with a supervising psychiatrist who handles Schedule II prescriptions
• Focusing on patients who can be managed with non-Schedule II alternatives (modafinil)
• Working for a platform that provides physician supervision as part of the infrastructure

Reimbursement note: Medicare reimburses NPs at 85% of the physician fee schedule when you bill under your own NPI. Private insurance often pays at parity, but not always. Given the lower reimbursement for mental health providers overall (22% less than other specialties in some markets), PMHNPs face similar financial headwinds as psychiatrists when accepting insurance. Cash-pay models may offer better economics.

The Medication Management Reality: Beyond Prescribing Authority

Whether you’re an MD or NP, managing narcolepsy via telehealth means dealing with practical challenges beyond just writing prescriptions:

Prior Authorizations Are a Time Sink

Narcolepsy medications often require prior authorization from insurance:

• Modafinil/armodafinil: Usually require PA and documentation of narcolepsy diagnosis (sleep study results)
• Stimulants: May require step therapy (trying modafinil first) or PA depending on insurer
• Sodium oxybate (Xyrem/Xywav): Has a REMS program — you must be specially enrolled to prescribe, and the patient can only get it through a single central pharmacy

Expect to spend 30-60 minutes per patient navigating these authorizations. Platforms that handle PA paperwork for you are worth their weight in gold. Otherwise, this is unpaid administrative time that cuts into your effective hourly rate.

Medication Shortages Are Real

The Adderall shortage that started in mid-2022 continues as of early 2024. Pharmacies regularly can’t fill stimulant prescriptions. You’ll field panicked calls from patients, need to call multiple pharmacies to find stock, or switch medications on short notice.

Having flexibility in your prescribing (knowing when to switch from amphetamine to methylphenidate, or from stimulants to modafinil) is crucial. Telehealth makes this easier in some ways — you can do a quick video visit to adjust the prescription and send it electronically to a different pharmacy in minutes.

PDMP Checks Are Mandatory

Every state requires prescribers to check the Prescription Drug Monitoring Program before prescribing controlled substances. In New York, you must check it every single time. In other states, it’s at initial prescription and then periodically (e.g., every 3-6 months for ongoing patients).

Make sure your telehealth platform integrates PDMP access or build it into your workflow. Skipping this step can result in regulatory action against your license.

Monthly Visits Are the Norm (At Least Initially)

Federal law prohibits refills on Schedule II medications. That means every 30 days, you’re writing a new prescription. Most psychiatrists and PMHNPs schedule monthly follow-ups during the first 3-6 months to:

• Titrate dose to optimal effect
• Monitor for side effects (elevated BP, tachycardia, insomnia, appetite suppression)
• Screen for misuse or diversion
• Adjust the treatment plan if symptoms aren’t controlled

Once a patient is stable, you can extend to every 3 months for visits, but you’ll still need to e-prescribe monthly scripts (some states allow post-dated prescriptions; others require monthly touchpoints).

Billing: These brief med checks code as 99213 (15 min, low complexity) or 99214 (25 min, moderate complexity). Efficient providers can see 3-4 narcolepsy patients per hour for follow-ups, making the economics work even at lower reimbursement rates.

Why Join a Telehealth Platform vs. Going Solo?

Let’s talk business. You could set up your own telehealth practice for narcolepsy patients. But here’s what you’d be signing up for:

DIY Marketing Costs (The Real Numbers):

• SEO: 6-12 months of consistent investment ($2,000-5,000/month for content, backlinks, technical optimization) before you start seeing meaningful patient flow
• Google Ads: Mental health keywords cost $15-40+ per click. Realistic cost per booked patient is $200-400+ after factoring in click-through rates, lead qualification, and no-shows
• Psychology Today/Zocdoc listings: Monthly subscription fees ($30-100+) plus competition with hundreds of other providers on the same search page. Zocdoc charges per booking ($35-100), which adds up fast
• Total patient acquisition cost: When you factor in ad spend, agency fees, staff time to handle leads, and months of SEO waiting, acquiring a qualified psychiatric patient through DIY marketing typically runs $200-500+ per new patient

Hidden Costs:

• Failed campaigns (most solo practitioners waste months and thousands testing ads that don’t convert)
• No-shows from cold leads who found you via a directory but aren’t actually ready to commit
• Staff time fielding phone calls and qualifying leads (or your own time if you’re solo)
• Legal and compliance infrastructure (telehealth platform, e-prescribing system, HIPAA-compliant video, malpractice insurance that covers telehealth)

The Platform Alternative:

Platforms like Klarity Health use a pay-per-appointment model. You pay a standard listing fee per new patient lead, but there’s:

• No upfront marketing spend or monthly subscription fees
• No wasted ad spend on clicks that don’t convert — you only pay when a qualified patient books with you
• Pre-qualified patients already matched to your specialty and availability (no cold leads calling to ask if you take their insurance)
• Built-in infrastructure: Telehealth platform, e-prescribing, scheduling, billing support
• Both insurance and cash-pay patient flow (diversified revenue streams)
• You control your schedule — only accept the patients you want to see

The Economic Case:

Instead of gambling $3,000-5,000/month on marketing channels with uncertain results, you pay only when a qualified patient shows up for an appointment. That’s guaranteed ROI vs. the DIY lottery where 80% of solo practitioners burn through their marketing budget before getting traction.

For narcolepsy specifically, the patient acquisition economics are even trickier solo. These patients need specialists. They’re not searching ‘psychiatrist near me’ — they’re searching ‘narcolepsy doctor telehealth’ or ‘can a psychiatrist prescribe Adderall for narcolepsy.’ Those niche keywords are expensive to rank for organically and even harder to convert via paid ads because the volume is low and the competition high.

A platform that already aggregates narcolepsy patients and matches them to qualified providers removes that entire headache. You get to focus on what you do best — clinical care — while the platform handles patient acquisition.

Practical Considerations & Provider FAQs

Q: Do I need to see sleep study results before prescribing narcolepsy meds?

A: Yes. Standard of care requires confirming the diagnosis with objective testing (polysomnogram + MSLT showing short sleep latency and sleep-onset REM periods). Most narcolepsy patients will come to you with a diagnosis from a sleep specialist. If not, you should refer them for testing before initiating controlled substances. Prescribing stimulants without documented narcolepsy diagnosis is a liability risk.

Q: Can I treat narcolepsy patients in multiple states via telehealth?

A: Only if you’re licensed in each state where patients reside. Telehealth doesn’t override state licensure requirements. The Interstate Medical Licensure Compact (for physicians) can expedite getting licensed in multiple states. For NPs, each state license is separate; there’s no compact for prescribing NPs. Budget accordingly for multi-state licensure fees ($300-1,000 per state, annually).

Q: What if my state’s telehealth rules change after 2025?

A: This is the big uncertainty. The DEA waiver expires December 31, 2025. After that, the agency may implement a special telemedicine registration, reinstate the in-person requirement, or (hopefully) make the flexibilities permanent. Platforms and professional organizations are actively lobbying for permanent telehealth prescribing authority given its success during the pandemic. Worst case: you’d need to arrange an initial in-person visit (with you or a local physician) before prescribing Schedule IIs via telehealth. Plan ahead.

Q: How do I handle a patient who’s misusing their medication?

A: Same protocols as ADHD stimulant management. Document carefully. If PDMP shows early refill requests, ‘lost’ prescriptions, or doctor shopping, have a direct conversation. You can:

• Require more frequent visits
• Switch to a non-controlled alternative (modafinil)
• Implement a treatment contract
• Taper and discontinue if misuse is confirmed

Your telehealth platform should have policies for flagging these situations and coordinating with your supervising physician (if you’re an NP) or with the patient’s other providers.

Q: What about malpractice insurance?

A: Most malpractice carriers now cover telehealth as part of standard policies, especially post-COVID. Confirm that:

• Your policy covers prescribing controlled substances via telehealth
• You’re practicing in states where you’re licensed
• You’re following accepted standards of care (PDMP checks, proper documentation, informed consent)

If you’re joining a telehealth platform, they often provide group malpractice coverage or require you to maintain your own policy with telehealth riders. Budget $3,000-8,000/year for a good policy depending on your state and case volume.

Why Narcolepsy Care Via Telehealth Is an Unmet Opportunity

Here’s the bottom line: Narcolepsy patients desperately need specialists who can prescribe their medications. Sleep medicine clinics are overwhelmed. Most primary care doctors won’t touch Schedule II stimulants for a rare sleep disorder. Neurologists often refer to sleep specialists who have 3-6 month waitlists.

You — whether you’re a psychiatrist or an experienced PMHNP in a favorable state — already have the expertise. You prescribe these medications for ADHD. You understand stimulant pharmacology, side effect management, and the regulatory compliance required for controlled substances.

The telehealth model removes geographic barriers. A narcolepsy patient in rural Texas or upstate New York can access your care without driving 200 miles to a sleep center. They get consistent, specialized medication management. You get a stable patient panel with predictable appointment schedules.

The regulatory landscape is manageable if you understand the rules:

• Psychiatrists can practice in nearly any state (with appropriate licensure) and prescribe everything narcolepsy patients need
• PMHNPs can do the same in full-practice states after gaining experience, or work collaboratively in restricted states
• The DEA waiver through 2025 provides breathing room; after that, be prepared to adapt

The economics work when you’re not burning money on patient acquisition. A platform that delivers pre-qualified narcolepsy patients to you — already matched to your availability, already seeking the exact medications you prescribe — turns what would be a marketing nightmare into a sustainable practice building opportunity.

If you’re considering expanding your scope into narcolepsy care, now is the time. The demand is there. The regulatory path is clearer than it’s ever been. And with the right telehealth infrastructure, you can provide genuinely needed care while building a financially viable practice.

Sources & Citations

1. Axios – ‘DEA, HHS Extend COVID-era Telehealth Prescribing Through 2025’ (November 18, 2024). Reports DEA extension of Ryan Haight Act waiver allowing controlled-substance prescribing via telehealth without initial in-person exam through December 31, 2025. www.axios.com

2. Texas Medical Board – ‘Who Can Prescribe Schedule II Drugs Under Physician Delegation?’ Official FAQ confirming Texas law restricts NP/PA Schedule II prescribing to hospital inpatient or hospice settings only. www.tmb.state.tx.us

3. California Board of Registered Nursing – ‘AB 890 Implementation’ (Updated 2024). Details 103 NP and 104 NP pathways to independent practice, including timeline that 104 NP certification begins January 2026. www.rn.ca.gov/practice/ab890.shtml

4. Florida Statutes Section 464.012 – Florida Nurse Practice Act (2021 compilation, current through 2024). Specifies 7-day maximum Schedule II supply for APRNs, with exemption for psychiatric nurses prescribing psychiatric medications. www.flsenate.gov

5. KFF Health News/MedicalXpress – ‘Narcolepsy Patients Face Dual Nightmare of Medication Shortages and Stigma’ (January 3, 2024). Reports narcolepsy prevalence (1 in 2,000 Americans), ongoing Adderall shortage impacts, and patient access challenges. medicalxpress.com

6. National Law Review – ‘New Florida Law Allows Telemedicine Prescribing of Controlled Substances’ (April 7, 2022). Legal analysis of Florida SB 312 explaining Schedule III-V telehealth allowance but Schedule II restrictions (psychiatric/inpatient/hospice exceptions only). natlawreview.com

7. Rivkin Radler LLP – ‘New Law Allows Experienced NPs to Practice Independently in NY’ (April 13, 2022). Summarizes New York’s 2023 Budget law making NP independence permanent after 3,600 hours of practice. www.rivkinrounds.com

8. Illinois General Assembly – Illinois Compiled Statutes, Nurse Practice Act (225 ILCS 65/65-43). Primary statute detailing Full Practice Authority requirements (4,000 hours + education) and Schedule II narcotic/benzodiazepine consultation requirements for FPA-NPs. www.ilga.gov

9. Pennsylvania Code Title 49, Chapter 21 – Prescribing Regulations for CRNPs (updated October 2025). Official state regulations specifying 30-day Schedule II limit and 90-day Schedule III-IV limit for nurse practitioners. www.pacodeandbulletin.gov

10. Axios Chicago – ‘Illinois Bill Could Make Mental Health Care More Affordable’ (March 6, 2025). Reports mental health providers paid 22% less than other physicians by private insurance, citing RTI International data. www.axios.com

11. Clinical Advisor – ‘Is Medicare’s 85% Reimbursement Rule Fair?’ (February 10, 2012). Confirms Medicare reimburses nurse practitioners and physician assistants at 85% of physician fee schedule for services. www.clinicaladvisor.com

12. Axios – ‘Texas Churches Step In as Mental Health Resources Lag’ (August 7, 2024). Cites Mental Health America data ranking Texas last nationally in mental health access and bottom five in workforce availability. www.axios.com

13. Axios – ‘Mental Health Parity and Behavioral Health Workforce Shortages’ (August 1, 2023). Reports projected psychiatrist shortage of up to 31,000 by 2024 and that 160+ million Americans live in mental health professional shortage areas, citing Psychiatric Services journal data. www.axios.com

14. New York State Education Department – ‘Collaborative Practice with Physicians’ (NP Practice Issues FAQ). Official guidance on collaborative agreement requirements for nurse practitioners in New York before reaching independent practice threshold. www.op.nysed.gov

15. BillTrack50 – Florida HB 771 Legislative Summary (2023). Documents failed 2023 Florida legislation that would have extended autonomous practice to psychiatric nurse practitioners. www.billtrack50.com

All citations verified as of February 2026. State regulations and telehealth rules are subject to change; providers should consult their state medical/nursing boards and legal counsel for current requirements.

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,person%20doctor%27s%20visit%20for%20the
• https://natlawreview.com/article/new-florida-law-allows-telemedicine-prescribing-controlled-substances#:~:text=controlled%20substances%20via%20telemedicine%2C%20with,more%20on
• https://www.ilga.gov/legislation/ILCS/details?ActID=1312&ActName=Nurse+Practice+Act.&ChapAct=225+ILCS+65%2F&Chapter=&ChapterID=24&MajorTopic=&Print=True&SeqEnd=17850000&SeqStart=16500000#:~:text=,drugs%2C%20such%20as
• https://www.ilga.gov/legislation/ILCS/details?ActID=1312&ActName=Nurse+Practice+Act.&ChapAct=225+ILCS+65%2F&Chapter=&ChapterID=24&MajorTopic=&Print=True&SeqEnd=17850000&SeqStart=16500000#:~:text=,require%20a%20physician%20name%3B
• https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=%2A%20103%20NP%20,focus%20of%20their%20National%20Certification
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=Please%20note%2C%20the%20law%20requires,certify%20104%20NPs%20until%202026
• https://www.tmb.state.tx.us/274-who-can-prescribe-schedule-ii-drugs-under-physician-delegation#:~:text=1.%20in%20a%20hospital%20facility,has%20elected%20to%20receive%20hospice
• https://www.flsenate.gov/Laws/Statutes/2021/Chapter464/All#:~:text=match%20at%20L1566%20limit%20the,455
• https://www.pacodeandbulletin.gov/Display/pacode?file=%2Fsecure%2Fpacode%2Fdata%2F049%2Fchapter21%2Fs21.284.html#:~:text=,may%20not%20delegate%20prescriptive%20authority